Abstract:Background The Asia-Pacific Colorectal Screening (APCS) score and a modified version that incorporates body mass index (BMI) has been widely recognised. This study aimed to compare the external validity of the APCS and the modified APCS to predict advanced colorectal neoplasia (ACN) in an asymptomatic Chinese population. Methods A prospective, multi-centre colonoscopy study was conducted in 7 endoscopic units across North Shanghai, China from 2016 to 2017. Average-risk subjects were recruited during their attendance for screening colonoscopy. Information on the predictors, including age, gender, family history of colorectal cancer and smoking status were collected by self-reported questionnaires. Body weight and height were measured by trained professionals. All screening colonoscopy procedures were performed by senior colonoscopists. The histology of all resected lesions was reported using the same diagnostic criteria by pathologists who were blinded to the study design. Cumulative scores were derived for each subject and categorised as average, moderate and high risk. The risk of ACN was assessed for each risk tier and the excess risk in moderate and high-risk tiers was compared with subjects with average risk. The C-statistics was employed to evaluate the discriminatory capability of both APCS scores. Results Among a total of 2813 enrolled subjects (mean age 58.7±8.4 years), 679 cases (24.1%) were found to have colorectal neoplasia, of which 142 (5.0%) had ACN and 29 patients (1.0%) had invasive cancers (table 1). In both APCS scoring systems, the risk of ACN was significantly different in low, moderate and high-risk tier (p<0.001, table 2). When compared with average risk subjects, those in the high-risk tier had a 3.06 (95% confidence interval (CI) 1.22, 7.68) and 4.07 (95% CI 1.48, 11.20) fold increased risk of ACN for the APCS and modified APCS system, respectively. The C-statistics of APCS and modified APCS were 0.645 (95% CI, 0.598, 0.683), and 0.648 (95% CI, 0.640, 0.696), respectively. Conclusions Both the APCS and modified APCS scores were similarly efficient to identify those subjects with high risk of can. Their feasibility and acceptability in different population groups should be further explored.Abstract IDDF2018-ABS-0134 Table 1 Participant characteristics and colonoscopy findings (n=2,813) Total Percentage (%) Gender (male) 1463 52.0 Ever smoking 931 33.1 Alcohol drinking 823 29.3 Family history in FDR 390 13.9 Hypertension 1004 35.7 Diabetes 293 10.4 Heart disease 156 5.5 COPD 19 0.7 Stroke 18 0.6 Cirrhosis 5 0.2 Fatty Liver 135 4.8 Personal cancer history (rather than CRC) 64 2.3 NSAID use 101 3.6 Normal 1755 62.4 Hyperplastic polyp 379 13.5 Non-advanced adenoma 537 19.1 Advance colorectal neoplasia 142 5.0 Cancer 29 1.0 Colorectal neoplasia 679 24.1 Chronic Obstructive Pulmonary Disease; CRC: colorectal cancer; FDR: first degree relative; NSAID: non-steroid Anti-Inflammatory DrugAbstract IDDF2018-ABS-0134 Table 2 The discriminatory capability of APCS and modified APCS in Chinese asymptomatic subjects (n=2,813) Scoring System Categories Case number ACN prevalence OR (95% CI) p-value APCS(age, gender, smoking, family history as predictors) Average (0–1) 177 5 (2.8) Referent < 0.001 Moderate (2–3) 1742 64 (3.7) 1.31 (0.52,3.30) 0.564 High (4–7) 894 73 (8.1) 3.06 (1.22,7.68) 0.017 Modified APCS(age, gender, smoking, family history, BMI as predictors) Average (0) 214 4 (1.9) Referent < 0.001 Moderate (1–2) 1253 35 (2.8) 1.51 (0.53,4.29) 0.440 High (3–6) 1333 96 (7.2) 4.07 (1.48,11.2) 0.006 APCS: Asia-Pacific Colorectal Screening, ACN: advanced colorectal neoplasia, OR: odds ratio, CI: confidence interval, BMI: body mass index

The Discriminatory Capability Of Existing Scores To Predict Advanced Colorectal Neoplasia: A Prospective Colonoscopy Study Of 5,899 Screening Participants

A Validated Scoring System to Predict Proximal Neoplasia for Colorectal Cancer Screening

A validated tool to predict colorectal neoplasia and inform screening choice for asymptomatic subjects.

Validation Of A Risk Prediction Score For Proximal Neoplasia In Colorectal Cancer Screening: A Prospective Colonoscopy Study

The Asia-Pacific Colorectal Screening score: a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects.

Development of a risk scoring system for predicting advanced colorectal neoplasia within subcentimetric polyps: A population-based study

An adjusted Asia-Pacific colorectal screening score system to predict advanced colorectal neoplasia in asymptomatic Chinese patients

IDDF2018-ABS-0134 Validation of the asia pacific colorectal screening (APCS) score and its modified version in prediction of advanced colorectal neoplasia in chinese asymptomatic subjects

Identification of Subjects at Risk of Proximal Advanced Neoplasia for Colorectal Cancer Screening

Risk Scoring Systems for Predicting the Presence of Colorectal Neoplasia by Fecal Immunochemical Test Results in Chinese Population

Prediction of advanced colorectal neoplasia based on metabolic parameters among symptomatic patients

Development and Validation of the Asia-Pacific Proximal Colon Neoplasia Risk Score

Establishment and Validation of Symptomatic Patients Colorectal Screening Score for Predicting Colorectal Neoplasia Risk.

Validation of the Asia-Pacific colorectal screening score and its modified versions in predicting colorectal advanced neoplasia in Chinese population

IDDF2022-ABS-0156 Risk Score for Advanced Colorectal Neoplasia in Symptomatic Individuals: a Derivation and Validation Study

The classification capability of the Asia Pacific Colorectal Screening score in Korea: an analysis of the Cancer Screenee Cohort

A risk scoring system for advanced colorectal neoplasia in high-risk participants to improve current colorectal cancer screening in Tianjin, China

IDDF2022-ABS-0183 Developing a Grading System for Advanced Colorectal Neoplasia in Patients with Diabetes

Development of a Risk Score for Colorectal Cancer in Chinese Males: A Prospective Cohort Study

A scoring model for predicting advanced colorectal neoplasia in a screened population of asymptomatic Japanese individuals

Validation of the Asia Pacific Colorectal Screening (APCS) score in a Western population: An alternative screening tool